FDA Inspection 1196232 — Reproductive Medicine Associates Of Philadelphia, P.c.
The FDA completed an inspection of Reproductive Medicine Associates Of Philadelphia, P.c. on January 24, 2023 in Langhorne, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 24, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Langhorne, PA (United States)